CAPRICOR THERAPEUTICS, INC. Other Long-term Debt, Noncurrent
CAPRICOR THERAPEUTICS, INC. (CAPR) had Other Long-term Debt, Noncurrent of $3.38 million as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:OtherLongTermDebtNoncurrent · last filed 2024-11-14
- 2024-09-30: Other Long-term Debt, Noncurrent $3.38M.
- 2024-06-30: Other Long-term Debt, Noncurrent $3.38M.
- 2024-03-31: Other Long-term Debt, Noncurrent $3.38M.
- 2023-12-31: Other Long-term Debt, Noncurrent $3.38M.
| Period end | Other Long-term Debt, Noncurrent |
|---|---|
| 2024-09-30 | $3.38M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $3.38M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $3.38M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $3.38M 10-Q · filed 2024-11-14 |
| 2023-09-30 | $3.38M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $3.38M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $3.38M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $3.38M 10-K · filed 2024-03-11 |
| 2022-09-30 | $3.38M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $3.38M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $3.38M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $3.38M 10-K · filed 2023-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |